Although I really enjoy psychology, like many anthropologists, I feel a deep ambivalence about some contemporary psychological theory and research.
Some of these problems are trivial and tendentious, to be honest, more the effects of pushing our own disciplinary preferences in the way research is presented or semiotic hair-splitting in theoretical terms than substantive concerns. But there are some more profound issues, touched on in recent posts like Daniel’s Neurotosh, Neurodosh and Neurodash and my post, Bench and couch: genetics and psychiatry. Ironically, I was reminded of one of the more serious issues while reading a piece a few weeks ago by psychologist and psychologist-sceptic Bruce Levine on Alternet, The Science of Happiness: Is It All Bullshit?
In a meandering way, this post is a reflection on one of anthropology’s consistent criticisms of psychology; the often unacknowledged role of psychiatry in shaping psyches. That is, the difficulty of studying a phenomenon when one is helping to create it and one’s theories influence your subjects’ accounts. When psychology is successful in breaking through into popular awareness, it becomes entangled with its subject, a kind of folk theory operating in the same space that psychologists seek to study. So this post is a kind of neuroanthropological reflection on clinical psychology as both research enterprise and world-making project, and the way the two come into conflict.
Specifically, Daniel’s post on Neurotosh and Levine’s story of John Stewart confronting Harvard happiness researcher, Prof. Tal Ben-Shahar, reminded me of the recent scandal surrounding psychiatrist Prof. Joseph Biederman. Biederman took large unreported consulting fees from pharmaceutical companies who manufactured anti-psychotic medicines while he was simultaneously encouraging psychiatrists to diagnose children with bipolar disorder, and then to prescribe their young patients anti-psychotic medicines. Senator Charles E. Grassley (R-Iowa) held hearings on the financial conflicts of interest as reported in The New York Times in Researchers Fail to Reveal Full Drug Pay, by Gardiner Harris and Benedict Carey. (For an earlier critical article, see the Boston Globe piece, Backlash on bipolar diagnoses in children.)